Syed Muhammad Areeb: Launch of two oncology products – Fulvedex and Temorel by Martin Dow Limited
Syed Muhammad Areeb, Product Manager of Oncology at
“Excited to Share a Milestone Achievement! I am thrilled to announce the successful launch of two groundbreaking oncology products: Fulvedex and Temorel by Martin Dow Limited.
This memorable event not only highlights the incredible hard work, dedication, and collaboration of our entire team but also marks my very first experience leading a product launch. It’s been an unforgettable journey!
This launch event was a testament to the dedication and meticulous planning by entire team. Every detail was thoughtfully executed to ensure a memorable and impactful experience. From the initial idea to the final implementation, the process has been a heartfelt effort driven by dedication and enthusiasm.
Special thanks to my senior management Mr. Asim Mustufa, Mr. Sana Ullah Khan for their unwavering support and leadership throughout this journey.
I would also like to extend my deepest gratitude to my supervisor, Dr. Nisha Saleem whose guidance and encouragement motivated me to face challenges and achieve success.” .
Source: Syed Muhammad Areeb/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023